Patch Biosciences Email Format
Biotechnology ResearchNew York, United States2-10 Employees
Patch Biosciences is a biotechnology research company based in New York, NY, focused on advancing gene therapy through large-scale DNA synthesis and machine learning. Its work centers on designing genetic sequences to yield more effective, specific, and durable genetic medicines. The organization operates with a small team. Its customers are researchers and developers pursuing gene therapies, who rely on an AI-enhanced approach to sequence design to improve therapeutic outcomes. In February 2024, Patch Biosciences was acquired by Ginkgo Bioworks.